Should Biotech Be On The Critical List?
May 11, 2022 at 01:10 AM EDT
The risk-off market has played havoc with the biotechs where the fundamentals have not changed as much as the valuation.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|